Seebri Breezhaler approved in Europe
October 4, 2012Sales and Marketing COPD, Novartis, Relvar, Seebri Breezhaler, Tudorza
Novartis has been given approval in Europe for its Seebri Breezhaler to be used as maintenance treatment for chronic obstructive …
Patent losses force change for Sanofi
October 3, 2012Sales and Marketing Avapro, BMS, Plavix, Sanofi, patent loss
Patent expiries are behind the decision by Sanofi and Bristol-Myers Squibb to radically restructure their long-term corporate alliance. The loss …
Non-executive directors of NHS Trust appointed
October 3, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christine Beasley, NHS, Sarah Harkness
Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority. Ms Beasley (pictured) …
Quality issues prompt Sanofi typhoid vaccine recall
October 3, 2012Manufacturing and Production Sanofi, Typhen Vi, recall
Sanofi has recalled several lots of its typhoid fever vaccine Typhim Vi on fears that a quality defect could compromise …
Bayer signs endometriosis pact
October 3, 2012Research and Development, Sales and Marketing Bayer, Evotec, endometriosis
Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …
Is it really safety first?
October 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche
The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …
Catalent and CTC Partner to Help Korean Pharma Take Their Products to Western Markets
October 2, 2012Research and Development
Somerset, NJ, September 13, 2012 – Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal …
Catalent Enters Into Commerical Supply Agreement with Vivus for Qsymia™ Once-Daily Combination Extended-Release Capsules
October 2, 2012Manufacturing and Production
Somerset, NJ, October 1, 2012 – Catalent Pharma Solutions announced that it has entered into a Supply Agreement with VIVUS, …
Survival boost for Votrient in mRCC
October 2, 2012Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient
GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …
Government launches Healthwatch England
October 2, 2012Sales and Marketing HealthWatch, NHS, government
The government has launched Healthwatch England, a new statutory body whose role is to ensure the public’s voice is heard …
Merck Serono has redeployed a fifth of axed Swiss staff
October 2, 2012Manufacturing and Production Geneva, Merck Serono
Merck Serono says it has redeployed 260 of 1,250 staff affected by the closure and downsizing of sites in Switzerland …
Lonza wins contract to make gene therapy for heart failure
October 2, 2012Manufacturing and Production Celladon, Lonza, Mydicar
Lonza has been awarded a contract by US firm Celladon for the manufacture of Mydicar, a gene therapy-based drug candidate …
Sigma-Aldrich invest in Scottish site
October 2, 2012Manufacturing and Production Bioreliance, Irvine, Scotland, Sigma-Aldrich
Sigma-Aldrich has announced an expansion of its operations in Scotland with the construction of a powder manufacturing facility at its …
Pharma manufacturing news in brief
October 2, 2012Manufacturing and Production BIA Seperations, Hovione, Lonza, Merck Millipore
Hovione invests in particle design, Lonza signs deal for ADC production plus bioprocess news from BIA Separations and Merck Millipore.
J&J cancer drugs get EU approval
October 2, 2012Sales and Marketing Cancer, Dacogen, EU, J&J, JJ, Velcade
Two of Johnson & Johnson’s key cancer drugs have been shown the green light from the European Commission. Janssen-Cilag International’s …
Cmed Clinical Services Strengthens Management Team
October 1, 2012Research and Development
HORSHAM, UK — September 13, 2012 – Cmed Clinical Services has today announced three new appointments to its management team …
BMS highlights Yervoy survival data
October 1, 2012Research and Development, Sales and Marketing BMS, Roche, Yervoy, Zelboraf
Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …
Sanofi appoints Paul Chew as chief medical officer
October 1, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Paul Chew, Sanofi
Sanofi has appointed Dr Paul Chew as chief medical officer and head of global medical affairs. Taking up his post …
FDA approves Bayer’s Stivarga
October 1, 2012Research and Development, Sales and Marketing Bayer, FDA, KRAS, Roche, Stivarga, avastin
The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …
Merck gives back vernakalant rights
September 28, 2012Sales and Marketing AF, Cardiome, Merck, vernakalant
Merck has dealt a further blow to Cardiome Pharma Corp by handing back all marketing and development rights for the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
